CTOs on the Move

GRO Biosciences

www.grobio.com

 
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.grobio.com
  • 700 Main Street North
    Boston, MA USA 02134
  • Phone: 617.903.8359

Executives

Name Title Contact Details

Funding

GRO Biosciences raised $25M on 11/01/2021

Similar Companies

ApprioHealth

ApprioHealth partners with healthcare organizations to provide Enrollment, Disability, Liability & Insurance Recovery solutions which improve operational and financial performance while positively impacting patient satisfaction. ApprioHealth`s approach combines proven workflows, leading and secure technology, and a certified team of healthcare RCM experts to consistently exceed customers` expectations.

Lutheran Home at Hollidaysburg

ALSM is a not-for-profit organization that has been serving families for 60 years. Our services and programs now span eight counties including Bedford, Blair, Cambria, Centre, Clearfield, Fulton, Huntingdon, and Somerset. ALSM currently offers care at

Vascular Solutions, Inc.

Vascular Solutions, Inc. (Vascular), incorporated in December 1996, is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Crystal Lake Healthcare

Crystal Lake Healthcare is a Bayville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.